New data for darolutamide confirm safety and improved efficacy across subgroups of patients with metastatic hormone-sensitive prostate cancer (mHSPC) by 40% and 70% respectively, compared to placebo ...
ONCOLife proudly presents an exclusive interview with Dr. Joana Reis, Global Medical Affairs Lead, Breast Imaging, Radiology at Bayer. In this session, we explore how AI-driven advancements are ...
Ariceum Therapeutics announced that the US FDA has cleared its investigational new drug (IND) application to commence a Phase I/II clinical trial of its proprietary radiolabelled peptide, 225Ac-SSO110 ...
The FDA has approved Datroway® (datopotamab deruxtecan-dlnk) for adult patients with unresectable or metastatic HR-positive, HER2-negative breast cancer. This innovative TROP2-directed antibody-drug ...
The U.S. FDA has approved a novel combination therapy using Lumakras® (sotorasib) and Vectibix® (panitumumab) for adults with KRAS G12C-mutated metastatic colorectal cancer (mCRC). This innovative ...
The Internet of Medical Things (IoMT) is set to radically change the quality of care and outcomes for millions of patients, while also increasing efficiency for clinicians and the organisations ...